MedPath

A Mobile Phone Based Medication Reminder Program

Not Applicable
Completed
Conditions
Medication Adherence
Interventions
Other: Daily reminders of taking medications
Other: Educational materials
Registration Number
NCT02793830
Lead Sponsor
Duke University
Brief Summary

This study evaluates the feasibility and acceptability of using mobile applications to improve medication adherence. Participants in the experimental group will receive educational materials and daily reminders through mobile applications. While, participants in the control group will receive only educational materials. After the intervention, interviews will be conducted among participants through phone calls.

Detailed Description

The purpose of this study is to improve medication adherence for Chinese patients with coronary heart disease (CHD) by using mobile applications. An exploratory randomized controlled trial (RCT, N=49) and interviews (n=15) will be included in this pilot study. The RCT will compare the effects of the medication adherence (MA, n=24) intervention and control condition (n=25) on the MA score (percent of prescribed antihypertensive drugs taken), and health outcomes (SBP and DBP obtained) of patients. The health outcomes will be assessed at enrollment and every three days after the intervention begins for thirty days. Feasibility will be determined by the number of patients enrolled, and retention (percent of patients who complete the study). Acceptability (read daily reminders and educational materials via mobile applications) will be evaluated through focus group interviews. All analyses will be performed using SAS 9.3 (Cary, NC). The potential risks of this study are minimal.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
49
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Mobile App GroupDaily reminders of taking medicationsParticipants in the experimental group will receive daily reminders and educational materials from mobile applications.
Mobile App GroupEducational materialsParticipants in the experimental group will receive daily reminders and educational materials from mobile applications.
Control GroupEducational materialsThe control group will receive the same educational materials, but no daily reminder.
Primary Outcome Measures
NameTimeMethod
Change in medication adherence scorebaseline, day 3, day 6, day 9, day 12, day 15, day 18, day 21, day 24, day 27, day 30.

Percent of prescribed antihypertensive drugs taken during the past three days.

Change in systolic blood pressure (SBP)baseline, day 3, day 6, day 9, day 12, day 15, day 18, day 21, day 24, day 27, day 30.
Change in diastolic blood pressure (DBP)baseline, day 3, day 6, day 9, day 12, day 15, day 18, day 21, day 24, day 27, day 30.
Secondary Outcome Measures
NameTimeMethod
Feasibility as measured by patient enrollmentapproximately seven weeks

Feasibility will be determined by the number of patients enrolled, and retention (percent of patients who complete the study).

Feasibility as measured by patient retentionapproximately seven weeks

Feasibility will be determined by retention (percent of patients who complete the study)

Acceptability as measured by patient interviewsapproximately seven weeks

Acceptability (read daily reminders and educational materials via mobile applications) will be evaluated through interviews.

© Copyright 2025. All Rights Reserved by MedPath